Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Rev Esp Patol ; 54(3): 193-196, 2021.
Article in Spanish | MEDLINE | ID: mdl-34175032

ABSTRACT

Hereditary leiomyomatosis (HL) is a rare autosomal dominant syndrome resulting from a mutation in the germline of the fumarate hydratase (FH) gene. Patients with this syndrome have an increased risk of cutaneous and uterine smooth muscle tumors as well as renal cancer. Renal carcinoma associated with hereditary leiomyomatosis (HLRCC) was recognized as a subtype of independent renal tumor in the 2016 WHO classification. We present a case of HLRCC occurring in a 39-year-old man with no family history or specific skin manifestations at the time of diagnosis.


Subject(s)
Carcinoma, Renal Cell/pathology , Kidney Neoplasms/pathology , Leiomyomatosis/pathology , Neoplastic Syndromes, Hereditary/pathology , Skin Neoplasms/pathology , Uterine Neoplasms/pathology , Adult , Carcinoma, Renal Cell/chemistry , Carcinoma, Renal Cell/genetics , Humans , Kidney Neoplasms/chemistry , Kidney Neoplasms/genetics , Leiomyomatosis/chemistry , Leiomyomatosis/genetics , Male , Neoplastic Syndromes, Hereditary/genetics , Skin Neoplasms/chemistry , Skin Neoplasms/genetics , Uterine Neoplasms/chemistry , Uterine Neoplasms/genetics
SELECTION OF CITATIONS
SEARCH DETAIL